LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.57 | 84.90 | 11847 | 7494 | 1.5807 | 1.1468 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.57 | 84.90 | 438 | 7494 | 0.0584 | 0.2890 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.57 | 84.90 | 11318 | 7494 | 1.5102 | 1.1317 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.27 | 84.90 | 839 | 7420 | 0.1131 | 0.4264 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.27 | 84.90 | 12073 | 7420 | 1.6270 | 1.1568 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.27 | 84.90 | 444 | 7420 | 0.0598 | 0.2924 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.27 | 84.90 | 11605 | 7420 | 1.5640 | 1.1436 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.98 | 84.90 | 787 | 7257 | 0.1084 | 0.4148 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.98 | 84.90 | 12434 | 7257 | 1.7132 | 1.1750 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.98 | 84.90 | 385 | 7257 | 0.0530 | 0.2656 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.98 | 84.90 | 11809 | 7257 | 1.6271 | 1.1576 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 84.90 | 784 | 7000 | 0.1120 | 0.4180 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 84.90 | 12750 | 7000 | 1.8213 | 1.1975 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 84.90 | 365 | 7000 | 0.0521 | 0.2575 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 84.90 | 12008 | 7000 | 1.7153 | 1.1769 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.66 | 84.90 | 566 | 285 | 1.9808 | 1.9551 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.66 | 84.90 | 652 | 285 | 2.2818 | 2.2037 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.36 | 84.90 | 638 | 322 | 1.9779 | 1.8499 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.36 | 84.90 | 719 | 322 | 2.2290 | 2.0324 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.06 | 84.90 | 757 | 365 | 2.0714 | 1.8262 | MN20160318_Q02 | H11 |